Indirect treatment comparisons of nivolumab versus regorafenib, cabozantinib and best supportive care after treatment with sorafenib for hepatocellular carcinoma

Authors:

Roskell N, Gregory J, Wisniewski T, Thompson G and De la Cruz C.

Publication type:

Conference Proceedings – Poster

Publication Name:

ISPOR Europe 2018

Citation:

Roskell N, Gregory J, Wisniewski T, Thompson G and De la Cruz C. Indirect treatment comparisons of nivolumab versus regorafenib, cabozantinib and best supportive care after treatment with sorafenib for hepatocellular carcinoma. ISPOR Europe 2018. Barcelona, Spain. 12-14 November 2018. Poster PCN17.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies